Fda

AI test improves bladder cancer risk assessment, treatment

The US Food and Drug Administration has granted Breakthrough Device Designation to Valar Labs' Vesta Bladder Risk Stratify Dx, an AI test designed to analyze standard pathology slides and eliminate cr